Chester County News and Community Website
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. secured a $3.17 million, five-year National Cancer Institute grant to advance an experimental radiopharmaceutical toward potential clinical testing in patients with non-small …
MTTI Lands $3.17 Million NCI Grant to Advance Lung Cancer Drug Read More WEST CHESTER, PA — Molecular Targeting Technologies Inc. is positioning its EvaThera platform for licensing and co-development opportunities across the radiopharmaceutical industry after Pharma Tech Outlook named the technology its …
West Chester Biotech Targets Radiopharma Partnerships Read More WEST CHESTER, PA — Molecular Targeting Technologies Inc. (MTTI) will present clinical data from 81 patients at the 5th Targeted Radiopharmaceuticals Summit, offering evidence that its Evans Blue drug delivery …
MTTI to Present 81-Patient Radiopharma Data at Oncology Summit Read More WEST CHESTER, PA — Molecular Targeting Technologies Inc. reported updated clinical data from 81 patients with gastroenteropancreatic neuroendocrine tumors treated with its experimental radiopharmaceutical EBTATE, results that the company says …
MTTI Reports Extended Disease Control Data in Neuroendocrine Tumor Study Read More WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) last week filed a legal complaint in the Chester County Court of Common Pleas against Dr. Xiaoyuan (Shawn) Chen, a former …
Biotech Showdown: MTTI Sues Ex-Consultant Over Stolen Cancer-Fighting Tech Read More WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has named Dr. Danielle Meyrick as its new Chief Medical Officer, strengthening its leadership team as it pushes forward with the development …
MTTI Appoints Veteran Radiopharmaceutical Leader Dr. Danielle Meyrick as Chief Medical Officer Read More